Bacteriostatic water (bac water) for peptides: solution stability

Bacteriostatic water, shortened to bac water in most US searches, is the preserved water laboratories reach for when a freeze-dried peptide has to go into solution in a vial that will be opened more than once. It is often treated as if it were a stability product. It is not: it keeps microbes in check, and it does nothing to stop a dissolved peptide from changing. This page is about that second problem, the chemistry of a peptide once it is in water, written for laboratory work. It covers what the US label says is actually in the vial, what benzyl alcohol does and does not do, the routes by which a dissolved peptide degrades, the variables that set their speed, and where a vial that arrives already in solution fits.

Research use only. This is a page about solution chemistry in the laboratory, not a recommendation to buy or use bacteriostatic water. The compounds we supply are for in-vitro research only, are not for human or veterinary use, and have not been evaluated by the FDA.

What the US label says is in the vial

In the United States, bacteriostatic water is a pharmacopeial (USP) product made by pharmaceutical manufacturers, and its labeling is public on DailyMed, the National Library of Medicine's label database. Hospira's listing is typical, and four of its lines matter to a chemist:

The pH line is the one most write-ups skip. A specification that tolerates anything from 4.5 to 7.0 is a statement that the liquid has no capacity to resist a change in acidity. Once a peptide salt dissolves in it, the peptide and its counter-ions decide the pH, not the water.

What benzyl alcohol does, and what it doesn't

Benzyl alcohol (C₆H₅CH₂OH) is a small aromatic alcohol. At just under one percent it is bacteriostatic: it slows the growth of bacteria introduced each time a closure is pierced, rather than sterilizing what is already there. A 2007 review of licensed sterile products found phenol and benzyl alcohol to be the two preservatives used most often in peptide and protein formulations, which is why it turns up in this context at all.

Three limits follow from what it is:

• It is not a sterilant. It holds back growth; it does not make a contaminated vial clean, and it is no substitute for aseptic technique.
• It is not a buffer. It has no acid-base group that works anywhere near neutral pH, so it contributes nothing to pH control.
• It is not inert toward proteins. In a 2004 study of a recombinant model protein (interleukin-1 receptor antagonist), benzyl alcohol bound weakly through hydrophobic contacts, shifted the population toward partially unfolded forms and sped up aggregation at 37 °C; sucrose partly offset the effect. That was a folded protein, and short peptides with little fixed structure have less to unfold. The general point stands, though: a preservative is an ingredient with chemistry of its own, and the review literature lists its effect on the active ingredient among the main criteria for choosing one.

Five ways a dissolved peptide changes

The pharmaceutical-stability literature sorts the changes a peptide or protein can undergo into chemical routes, where covalent bonds are made or broken, and physical routes, where no bond changes but the molecules no longer sit where, or how, they started. Manning, Patel and Borchardt laid out that division in 1989, and the 2010 update kept it. For short research peptides, five routes cover most of what goes wrong:

Two of these deserve numbers, because they show how large the effects can be.

Deamidation can be fast. In Geiger and Clarke's model hexapeptide Val-Tyr-Pro-Asn-Gly-Ala, the asparagine deamidated with a half-life of 1.4 days at 37 °C and pH 7.4, through a succinimide intermediate that went on to give a mixture of normal and iso-aspartyl products. Replacing the glycine after the asparagine with leucine or proline slowed the reaction 33- to 50-fold. Sequence context, not just storage conditions, sets the clock.

Adsorption can empty a solution. Kristensen and colleagues measured three cationic membrane-active peptides in ordinary glass and plastic sample containers and found that, at typical experimental concentrations, 90% or more of the peptide could be lost to the container walls. Goebel-Stengel and colleagues showed that how much of a given peptide could be retrieved from a tube depended on both the surface and the peptide; siliconizing the tubes made things worse, while adding albumin as a carrier helped. A solution that has quietly lost most of its peptide to the vial wall still looks perfectly clear.

pH: the variable bac water leaves open

Because the water carries no buffer, the pH of a fresh peptide solution is set by whatever was dissolved in it. Synthetic peptides are commonly isolated as salts, with trifluoroacetate and acetate the usual counter-ions, and those salts together with the peptide's own acidic and basic side chains decide where the pH lands. Two lots of the same peptide with different counter-ions can finish at different pH values in identical bac water.

That matters because the routes in the table pull in different directions. Acid favors cleavage next to aspartate; neutral-to-basic conditions favor deamidation; metal complexes have a window of their own (the copper in GHK-Cu is held by nitrogen donors that let go once they are protonated, as the GHK-Cu guide explains). For many short peptides the slowest overall change sits somewhere in the mildly acidic range, but the optimum belongs to the sequence, which is why formulation work measures it instead of assuming it.

A buffer can pin pH where a sequence needs it. Buffers bring side effects of their own, however: some bind metal ions, some shift pH as they freeze, and the identity of the buffer can matter as much as the pH it is set to. The cofactor section below has a measured example.

Temperature, freezing and light

Temperature. Every chemical route in the table runs faster when warm. Holding a solution at 2-8 °C is the single most effective control available, and it is the reason a solution has to travel cold-chain.

Freezing. Freezing does not simply pause a solution. As ice forms, the peptide and any salts are squeezed into a shrinking liquid fraction, and molecules meet a large ice-liquid interface. In Cao and colleagues' study of model enzymes, fast freezing combined with slow thawing did the most harm, which they attributed to interfacial effects on the way down and ice recrystallization on the way up; when buffer components crystallized during freezing, the resulting pH shift cut activity further. That is why ready-made peptide solutions carry a do-not-freeze instruction, and why repeated freeze-thaw cycling is the textbook way to degrade one.

Light. In proteins, photo-oxidation starts mainly at tryptophan, tyrosine, phenylalanine and cysteine or cystine, according to Kerwin and Remmele's review. A sequence without those residues is less exposed, but keeping vials in their carton is the default either way, and copper complexes are light-sensitive in their own right.

Redox cofactors are a different problem

NAD⁺ is not a peptide, and it fails in a different way. Its oxidized and reduced forms have nearly opposite weak points: NAD⁺ is the fragile one in alkaline solution, NADH the fragile one in acid. That rules out a simple "keep it acidic" rule and puts the buffer itself in play. Wolfe and colleagues followed both forms in sodium phosphate, HEPES and Tris for up to 43 days. In Tris, NADH fell by about 4 µM a day at 19 °C and 11 µM a day at 25 °C, leaving more than 90% and about 75% respectively at the end; phosphate and HEPES ran at up to 34 µM a day. Same molecule, similar temperatures, a several-fold difference decided by which buffer it sat in. Plain bacteriostatic water offers none of that control.

Where a pre-mixed vial fits

Everything above applies from the moment a peptide meets water. With a lyophilized powder, that moment happens in the user's laboratory, along with every choice that comes with it: which solvent, what pH results, whether the solid has fully dissolved, whether the vial foamed (an air-liquid interface is one more surface for molecules to unfold or stick to), and what the container is made of.

A pre-mixed vial moves that step upstream. The solution is prepared once, under controlled conditions, at a stated concentration, and every vial in the batch comes from the same preparation. What it cannot do is suspend the chemistry. A solution keeps aging, which is why it has to stay at 2-8 °C, sealed, out of light and unfrozen, and why its useful life is shorter than a dry powder's. The pre-mixed vs lyophilized guide weighs that trade-off in both directions, and how to store research peptides covers day-to-day handling.

Our BPC-157, TB-500 and GHK-Cu vials ship pre-mixed, as do the Wolverine Stack and the Klow Stack, so for them there is no bacteriostatic water step at all. Orders are dispatched cold-chain from the warehouse that serves the United States, with tracked delivery across the country next business day, priced in US dollars and payable by Visa, Mastercard or Apple Pay. Batch certificates for the BPC-157, TB-500 and GHK-Cu vials are published in our COA library, and the Certificate of Analysis guide explains how to read one.

What to record when a peptide is in solution

A solution's history is part of its identity. For any peptide solution kept in a laboratory, a short record makes a later result interpretable:

1. Solvent. Its identity, lot and expiry, and for preserved water the stated preservative content.
2. pH. Measured once the peptide is in solution, not inferred from the solvent's label.
3. Container. Glass or which plastic, and whether the surface was treated.
4. Temperature history. When the solution was made, where it has been kept, and any time it spent warm.
5. Freeze-thaw count. For a solution, ideally zero.
6. Light. Carton or open bench.
7. Source batch. The lot number that ties the material back to its certificate.

Where this page stops

In the United States bacteriostatic water is a prescription-labeled pharmaceutical, and this page is not a guide to obtaining it or to preparing anything for use. We do not publish dosing, reconstitution-for-use volumes or administration information for any compound. Our products are not FDA-approved drugs, have not been evaluated by the FDA, and are supplied for in-vitro laboratory research only, not for human or veterinary use.

Related reading

• Pre-mixed vs lyophilized peptides · How to store research peptides · What is GHK-Cu? · What is NAD⁺? · What is a Certificate of Analysis?